Groundbreaking Discovery: Iowa State Researchers Revolutionize Blood Stem Cell Production

Iowa State researchers make huge discovery for creating blood stem cells in the lab

In an era where scientific breakthroughs are increasingly becoming the bedrock of medical advancements, a team of researchers at Iowa State University has made a monumental discovery that could potentially transform the landscape of regenerative medicine. As reported by Teodora Mitov, their pioneering research has uncovered a possible method to create blood stem cells in […]

Celularity Revolutionizing Cancer Treatment: The Breakthrough of Stem Cell Therapy

celularity-logo

A New Era in Oncology In an exciting development for the field of oncology, Celularity Inc., a leading biotechnology company, is set to present compelling in vivo data at the AACR Annual Meeting 2024. This data showcases the significant impact of their groundbreaking stem cell therapy, PT-CD16, in reducing cancer tumors. Derived from human placental […]

Stem Cell-Based Therapies for Lymphoma

image representing stem cell therapies for lymphoma

Understanding Lymphoma and the Promise of Stem Cell Therapy Lymphoma, a type of blood cancer that affects the lymphatic system, presents a significant health challenge worldwide. It’s a complex disease with various subtypes, each requiring a unique approach to treatment. In recent years, stem cell therapy has emerged as a beacon of hope for many […]

Hematopoietic Stem Cell Transplantation (HSCT) for Leukemia: A Modern Lifeline

cartoon image of male patient undergoing HSCT for leukemia

When faced with leukemia, a type of cancer that launches a stealthy and devastating attack on the body’s blood-forming tissues, patients and their families often feel as though they’ve been cast adrift in a tempestuous sea. However, amidst these turbulent waters, Hematopoietic Stem Cell Transplantation (HSCT) emerges as a life-saving beacon of hope, offering a […]

IN8bio Announces Major Advancements in Leukemia and Glioblastoma Treatments

IN8bio logo

On October 12, 2023, IN8bio, a pioneering clinical-stage biopharmaceutical company, made a significant announcement regarding its gamma-delta T cell therapies. The company has successfully completed the enrollment for its Phase 1 study of INB-100, a potential treatment for leukemia patients. This marks a significant step forward as INB-100 is being evaluated for its safety when […]

Coeptis Therapeutics Expands Collaboration with University of Pittsburgh on CAR NK Cell Therapy

Coeptis Therapeutics

Biotech startup Coeptis Therapeutics announced an expanded partnership with the University of Pittsburgh today, licensing additional CAR NK cell therapy technology developed at Pitt. This new agreement builds on their existing collaboration around a CD19-targeting CAR NK cell therapy for blood cancers. The new technology, known as SNAP CAR NK cells, allows for more precise […]

Factors to Consider When Selecting Mismatched Unrelated Donors for Stem Cell Transplantation

Factors to Consider When Selecting Mismatched Unrelated Donors for Stem Cell Transplantation

In a recent interview at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX, Dr. Rohtesh Mehta from the Fred Hutchinson Cancer Research Center in Seattle, WA, discussed the crucial factors to consider when selecting mismatched unrelated donors (MMUDs) for stem cell transplantation (SCT). Historically, there were limited […]

Beam’s Breakthrough: Revolutionizing Genetic Medicine?

Beam Therapeutics logo

Beam Therapeutics Inc., a leading biotechnology company specializing in precision genetic medicines through base editing, has recently made a significant announcement. In August, the company initiated treatment for its first patient with BEAM-201, a quadruplex-edited allogeneic CAR-T cell investigational therapy. This therapy is currently under evaluation in a Phase 1/2 clinical trial aimed at treating […]